(Reuters) - Regenerative medicine maker MiMedx Group Inc is under federal investigation related to two business practices, Bloomberg reported on Monday, citing people familiar with the matter.

U.S. Justice Department probing MiMedx's business practices: Bloomberg
Read More
Bagikan Berita Ini
0 Response to "U.S. Justice Department probing MiMedx's business practices: Bloomberg"
Posting Komentar